Jan Basile to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Jan Basile has written about Angiotensin Receptor Antagonists.
Connection Strength
1.012
-
Meta-analysis concludes angiotensin receptor blocker use increases the risk of developing cancer: concerns about the science and the message. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):661-3.
Score: 0.334
-
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):809-12.
Score: 0.334
-
Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112.
Score: 0.184
-
Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):1-4.
Score: 0.085
-
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66.
Score: 0.075